The Current Ratio of Anavex Life Sciences Corp (AVXL) is
11.60.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-09-30 |
11.60
|
| 2024-09-30 |
8.86
|
| 2023-09-30 |
12.35
|
| 2022-09-30 |
14.97
|
| 2021-09-30 |
14.96
|
| 2020-09-30 |
4.73
|
| 2019-09-30 |
5.06
|
| 2018-09-30 |
6.69
|
| 2017-09-30 |
7.72
|
| 2016-09-30 |
2.94
|
| Ticker |
Name |
Value |
|
ABBV
|
AbbVie Inc.
|
0.67
|
|
CRTX
|
Cortexyme Inc
|
7.85
|
|
KNSA
|
Kiniksa Pharmaceuticals International, PLC
|
3.79
|
|
950220.KQ
|
Neoimmunetech Inc
|
3.08
|
|
ADAP
|
Adaptimmune Therapeutics PLC
|
2.92
|
|
ADVM
|
Adverum Biotechnologies Inc
|
5.73
|
|
AFMD
|
Affimed NV
|
3.25
|
|
ANNX
|
Annexon, Inc.
|
5.68
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
0.82
|
|
GILD
|
Gilead Sciences, Inc.
|
1.55
|
|
ORIC
|
ORIC Pharmaceuticals, Inc.
|
14.13
|
|
TSHA
|
Taysha Gene Therapies, Inc.
|
12.23
|
|
AKRO
|
Akero Therapeutics Inc
|
19.25
|
|
BDTX
|
Black Diamond Therapeutics Inc
|
8.42
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
CLNN
|
Clene Inc
|
0.83
|
|
EPIX
|
ESSA Pharma Inc
|
38.79
|
|
ITOS
|
iTeos Therapeutics Inc
|
12.75
|
|
MRUS
|
Merus NV
|
6.54
|
|
PRTA
|
Prothena Corporation PLC
|
7.72
|
|
SGTX
|
Sigilon Therapeutics Inc
|
2.40
|
|
950200.KQ
|
Psomagen Inc
|
1.67
|
|
ALGS
|
Aligos Therapeutics, Inc.
|
3.90
|
|
INBX
|
Inhibrx Biosciences Inc
|
3.93
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
PASG
|
Passage Bio Inc
|
2.07
|
|
PRAX
|
Praxis Precision Medicines, Inc.
|
10.22
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
4.40
|
|
950160.KQ
|
Kolon TissueGene Inc
|
0.24
|
|
ARCT
|
Arcturus Therapeutics Holdings Inc
|
6.64
|
|
MRSN
|
Mersana Therapeutics Inc
|
2.19
|
|
NWBO
|
Northwest Biotherapeutics Inc
|
0.06
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.90
|
|
BTAI
|
BioXcel Therapeutics Inc
|
0.83
|
|
EPZM
|
Epizyme Inc
|
4.56
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
4.41
|